Choroideremia
6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 4D-110 for choroideremia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AAV-mediated REP1 gene replacement for choroideremia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BIIB112 for choroideremia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| rAAV2.REP1 for choroideremia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| rAAV2.REP1 vector for choroideremia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Timrepigene emparvovec for choroideremia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |